Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PLX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
18 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 1
102 filers reported a long position in PLX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $9.4M | 4M | +11.9% |
| RENAISSANCE TECHNOLOGIES LLC | $2.6M | 1.1M | -10.5% |
| STATE STREET CORP | $2.3M | 983.6K | +1.1% |
| GEODE CAPITAL MANAGEMENT, LLC | $2.3M | 980K | +13.3% |
| NORTHERN TRUST CORP | $2.1M | 922.3K | +4.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.2M | 510.6K | +18.1% |
| Stratos Wealth Partners, LTD. | $1.2M | 500K | Unchanged |
| DIMENSIONAL FUND ADVISORS LP | $1.1M | 493.4K | +66.2% |
| GOLDMAN SACHS GROUP INC | $1.1M | 475.9K | +89.4% |
| MARSHALL WACE, LLP | $1.1M | 452.8K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.